Best CAR T-cell therapy Doctors in test — TOP 39

Dr. Ram Ron specializes in CAR T-cell therapy at Sourasky Medical Center (Ichilov), bringing extensive expertise to this advanced treatment.

• Focused on cutting-edge cellular therapies
• Works at a leading medical center for oncology
• Dedicated to personalized treatment approaches

Head of Pediatric Oncohematology at Dana Dwek Children's Hospital – Dr. Ronit El Hasid specializes in bone marrow and blood transplants for children.

• Performed 300+ transplant procedures
• Published 50+ medical papers
• Presented research at 40+ conferences
• Fellow of American Association for Hematology
• Trained at City of Hope Hospital in Los Angeles

Dr. Ron Ram has performed several hundred stem cell transplants and published over 30 scientific articles in hematology and oncology.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Fellowship-trained at New York Medical College
• Specializes in hematologic malignancies and transplants
• Academic contributor with textbook chapter authorship

Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.

She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.

She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Professor Bulent Eser specializes in hematology with a focus on cutting-edge treatments like CAR T-cell therapy at Medical Park Antalya Hospital Complex.

• Over 36 years of experience of experience in hematology and internal medicine
• Member of the European Group for Blood and Marrow Transplantation
• Professor at Erciyes University, Faculty of Medicine
• Active in clinical research and advanced hematologic treatments

Professor Bozkurt trained in pediatric oncology at top US and Turkish hospitals, with extensive experience in stem cell therapy. As Clinical Director of Pediatric Hematology-Oncology at Medical Park Bahcelievler, he leads one of Turkey's top units.

• Expert in pediatric bone marrow transplantation and CAR T-cell therapies
• Specialized training at Cincinnati Children's Hospital and Harvard's Dana-Farber Cancer Institute
• Published 40+ research papers on childhood cancers and stem cell therapies
• Vice Director of the Stem Cell Transplant Unit at Medical Park
• Active member of EBMT and SIOP – key groups advancing cellular therapies

Specialist in bone marrow transplantation at SJD Barcelona Children's Hospital, focusing on pediatric hematology.

• Expertise in CAR T-cell therapy for children
• Works at one of Spain's leading pediatric hospitals
• Dedicated to advanced treatments for hematological conditions

Dr. Francesc Cobo Valien specializes in oncohematology with a focus on lymphoma and leukemia, backed by extensive research and prestigious awards.

• Graduated from the University of Barcelona in 1990
• Specialized in oncohematology at Hospital Clínic de Barcelona
• Recipient of multiple research grants and awards
• Expert in CAR T-cell therapy for hematologic malignancies

Specializes in CAR T-cell therapy at Lu Daopei Hematology Hospital, a leading center for hematologic treatments.

• Focuses on innovative cellular therapies
• Works at a renowned hematology hospital
• Expert in managing complex hematologic cases

Dr. Michael Shapira specializes in Bone Marrow Transplantation at Sourasky Medical Center (Ichilov), with extensive experience in the field.

• Graduated from Hebrew University Medical School in 1999
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in Bone Marrow Transplantation at Hadassah
• Fluent in English and Hebrew

Director of pediatric hematology oncology at Sourasky Medical Center – specializes in CAR T-cell therapy for children with blood disorders and sarcomas.

• Senior pediatrician at Children's Hospital Dana
• Trained at Rizzoli Orthopaedic Institute – one of the world's leading centers for bone cancer
• Member of ISPHO – Israel's pediatric hemato-oncology association
• Coordinates sarcoma treatment programs for children

With 34 years of experience of experience, Dr. Aviv specializes in CAR T-cell therapy at Sourasky Medical Center (Ichilov Clinic).

• Focuses exclusively on oncohematology
• Extensive experience with advanced cellular therapies
• Practices at one of Israel's leading medical centers

Dr. Kodchanut specializes in CAR T-cell therapy at Intrarat Hospital, leveraging advanced hematology training to improve patient outcomes.

• Graduated with honors from Naresuan University Hospital's MD program
• Thai Board certified hematologist with specialized fellowship at Thammasat University
• Pioneer in hematology services at Huahin Hospital since 2020
• Co-author of research on cancer-associated venous thromboembolism risk models

Dr. Yair has made significant contributions to hematology, particularly in chronic lymphocytic leukemia, with numerous awards and published research.

• Recipient of multiple prestigious awards including the Klitzberg Oncology Award
• Member of both Israeli and American Hematology Associations
• Extensive training in hematology at Tel Aviv Medical Center
• Active in research with grants from the Israeli Science Foundation

Dr. Mustafa Serkan Alemdar specializes in CAR T-cell therapy at Medical Park Antalya Hospital Complex, with a strong background in medical oncology.

• Completed medical oncology training at Akdeniz University
• Over 20 years of experience of experience in medical oncology
• Worked at top hospitals including Akdeniz University Hospital
• Dedicated to advancing cancer treatment through innovative therapies

Dr. Danylesko specializes in CAR T-cell therapy at Sheba Medical Center, focusing on personalized treatment approaches.

• Experienced in administering CAR T-cell therapy to a diverse patient population
• Collaborates with multidisciplinary teams to optimize treatment plans
• Engages in ongoing research to improve CAR T-cell therapy outcomes

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.